A Novel Oncogenic Driver in a Lung Adenocarcinoma Patient Harboring an EGFR-KDD and Response to Afatinib

Introduction: Oncogenic mutations in the epidermal growth factor receptor (EGFR) occur frequently in patients with lung cancer. These mutations may serve as critical predictive biomarkers in patients with non-small cell lung cancer (NSCLC). Among them, EGFR exon 18–25 kinase domain duplication (EGFR...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Dong, Li, Xing-liang, Wu, Biao, Zheng, Xiao-bin, Wang, Wen-xian, Chen, Hua-fei, Dong, Yi-yu, Xu, Chun-wei, Fang, Mei-yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325976/
https://www.ncbi.nlm.nih.gov/pubmed/32656077
http://dx.doi.org/10.3389/fonc.2020.00867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325976/
https://www.ncbi.nlm.nih.gov/pubmed/32656077
http://dx.doi.org/10.3389/fonc.2020.00867

Ejemplares similares